These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 5159676)
1. Potentially serious side-effects of high-dose twice-weekly rifampicin. Poole G; Stradling P; Worlledge S Postgrad Med J; 1971 Nov; 47(553):727-47. PubMed ID: 5159676 [TBL] [Abstract][Full Text] [Related]
2. Potentially serious side effects of high-dose twice-weekly rifampicin. Poole G; Stradling P; Worlledge S Br Med J; 1971 Aug; 3(5770):343-7. PubMed ID: 5314737 [TBL] [Abstract][Full Text] [Related]
3. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore. Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598 [TBL] [Abstract][Full Text] [Related]
4. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis. Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040 [No Abstract] [Full Text] [Related]
5. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3. Oka S; Sasaki M; Kobayashi T; Matsuda T Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627 [No Abstract] [Full Text] [Related]
6. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months. Am Rev Respir Dis; 1977 Nov; 116(5):807-20. PubMed ID: 411405 [No Abstract] [Full Text] [Related]
8. Thrombocytopenia--a rare but potentially serious side effect of initial daily and interrupted use of rifampicin. Lee CH; Lee CJ Chest; 1989 Jul; 96(1):202-3. PubMed ID: 2736979 [TBL] [Abstract][Full Text] [Related]
9. Short course chemotherapy for tuberculosis in children. Padmini R; Srinivasan S; Nalini P; Mahadevan S J Trop Pediatr; 1993 Dec; 39(6):361-4. PubMed ID: 8133559 [TBL] [Abstract][Full Text] [Related]
10. [Scrofuloderma with hypersensitivity to rifampicin and pyrazinamide, treated with a combination therapy including ofloxacin]. Belghith I; Badri T; Zaiem A; Benmously R; Mokhtar I Presse Med; 2012 Apr; 41(4):437-9. PubMed ID: 22000406 [No Abstract] [Full Text] [Related]
11. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin]. González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262 [No Abstract] [Full Text] [Related]
12. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council. Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200 [TBL] [Abstract][Full Text] [Related]
13. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199 [TBL] [Abstract][Full Text] [Related]
14. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis]. Zierski M; Bek E Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146 [No Abstract] [Full Text] [Related]
15. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial. Newman R; Doster B; Murray FJ; Ferebee S Am Rev Respir Dis; 1971 Apr; 103(4):461-76. PubMed ID: 4994459 [No Abstract] [Full Text] [Related]
16. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens. Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733 [TBL] [Abstract][Full Text] [Related]
17. [Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case]. Beji M; Louzir B; Ben Rhomdane N; Zouari M; Mtimet B; Daghfous J Tunis Med; 1995 May; 73(5):201-3. PubMed ID: 9507284 [No Abstract] [Full Text] [Related]
18. Acute renal failure and severe thrombocytopenia induced by rifampicin: report of a case. Juang YC; Tsao TC; Chiang YC; Lin JL; Tsai YH J Formos Med Assoc; 1992 Apr; 91(4):475-6. PubMed ID: 1358323 [TBL] [Abstract][Full Text] [Related]
19. Letter: Permanent renal damage with rifampicin. Cochran M; Morrhead PJ; Platts M Lancet; 1975 Jun; 1(7922):1428. PubMed ID: 49593 [No Abstract] [Full Text] [Related]
20. Rifampin-induced acute renal failure. Davis CE; Carpenter JL; Ognibene AJ; McAllister CK South Med J; 1986 Aug; 79(8):1012-5. PubMed ID: 3738573 [No Abstract] [Full Text] [Related] [Next] [New Search]